THEV0 - Overview: Thalassemia Summary Interpretation, Blood

Incorporating and summarizing subsequent molecular results into an overall interpretation for the THEV1 / Thalassemia and Hemoglobinopathy Evaluation, Blood and Serum

DLAU - Overview: D-Lactate, Urine

Preferred test for diagnosing D-lactate acidosis, especially in patients with jejunoileal bypass and short-bowel syndrome

UNHB - Overview: Hemoglobin Stability, Blood

Work-up of congenital hemolytic anemias

HK1 - Overview: Hexokinase Enzyme Activity, Blood

The evaluation of individuals with Coombs-negative chronic hemolysis

HKC - Overview: Hexokinase Enzyme Activity, Blood

The evaluation of individuals with Coombs-negative chronic hemolysis

ETX - Overview: Ethosuximide, Serum

Monitoring ethosuximide therapy Determining compliance Assessing ethosuximide toxicity

PBHA - Overview: Lead, Hair

Detecting lead exposure using hair specimens

LASF1 - Overview: Lactic Acid, Spinal Fluid

Aid in differentiating between bacterial and viral meningitis Aid in identifying increased anaerobic glycolysis or hypoxia associated with bacterial meningitis, cerebral infarction, cerebral arteriosclerosis, intracranial hemorrhage,...

MURA - Overview: Lysozyme (Muramidase), Plasma

As a screening test for ocular sarcoidosis Confirming marked increases in the granulocyte or monocyte pools as in granulocytic or monocytic leukemias, myeloproliferative disorders, and malignant histiocytosis Following the course of...

IOD - Overview: Iodine, Serum

Determining iodine overload using serum specimens Monitoring iodine levels in individuals taking iodine-containing drugs

MEX - Overview: Mexiletine, Serum

Assessing achievement of optimal therapeutic mexiletine concentrations Assessing potential mexiletine toxicity

ADMI - Overview: ADAMTS13 Interpretation

Technical interpretation of testing performed to assist in the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura

NH3V - Overview: Ammonia, Plasma

Assisting in the diagnosis of hepatic coma Investigating and monitoring treatment for inborn errors of metabolism Evaluating patients with advanced liver disease

SGUR - Overview: Specific Gravity, Random, Urine

As a partial assessment of the kidney's ability to concentrate urine

SP7CS - Overview: Septin-7 Antibody, Cell-Binding Assay, Serum

Detecting septin-7 IgG by cell-binding assay using serum specimens

TPI1 - Overview: Triosephosphate Isomerase Enzyme Activity, Blood

Evaluating individuals with chronic nonspherocytic hemolytic anemia Evaluating individuals with early onset neurologic impairment Genetic counseling for families with triosephosphate isomerase deficiency

CZPS - Overview: Clonazepam and 7-Aminoclonazepam, Serum

Assessing patient compliance Monitoring for appropriate therapeutic level Assessing clonazepam toxicity

CDP - Overview: Chlordiazepoxide and Metabolite, Serum

Monitoring chlordiazepoxide therapy Assessing toxicity

SP7CC - Overview: Septin-7 Antibody, Cell-Binding Assay, Spinal Fluid

Detecting septin-7 IgG by cell-binding assay using cerebrospinal fluid specimens

PERAM - Overview: Perampanel, Serum

Monitoring serum concentration of perampanel, in specific clinical conditions (ie, severe kidney impairment, mild to moderate hepatic impairment, and end-stage kidney disease) Assessing compliance Assessing potential toxicity

RPHOC - Overview: Phosphorus, Random, Urine

Evaluation of hypo- or hyperphosphatemic states Evaluation of patients with nephrolithiasis

APBCC - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Cell-Binding Assay, Spinal Fluid

The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Evaluating AP3B2 (adaptor protein 3 beta2)-IgG by cell-binding assay using spinal fluid specimens

ETGL - Overview: Ethylene Glycol, Serum

Confirming and monitoring ethylene glycol toxicity

SSF1 - Overview: Nocardia Stain, Varies

Detecting Nocardia species and other partially-acid fast aerobic actinomycetes in clinical specimens

FLEC - Overview: Flecainide, Serum

Optimizing flecainide dosage Assessing flecainide toxicity Monitoring compliance

HBEL0 - Overview: Hemoglobin Electrophoresis Summary Interpretation

Incorporating and summarizing results into an overall evaluation for the HBEL1 / Hemoglobin Electrophoresis Evaluation, Blood

BALPF - Overview: B-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL), Pediatric, FISH, Varies

Detecting, at diagnosis, recurrent common chromosome abnormalities associated with B-cell acute lymphoblastic leukemia/lymphoma (B-ALL/LBL) and Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) in pediatric patients...

CILPF - Overview: Congenital Infantile Leukemia, FISH, Tissue

Detecting a neoplastic clone associated with the common chromosome abnormalities and classic rearrangements seen in infant patients with leukemia using tissue specimens

ADMPU - Overview: Addiction Medicine Profile with Reflex, 22 Drug Classes, High Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine

Detecting drug use involving stimulants, barbiturate, benzodiazepines, cocaine, opioids, tetrahydrocannabinol, alcohol, and nicotine This test is not intended for use in employment-related testing.

POSV - Overview: Post Vasectomy Check, Semen

Determining absence or presence of sperm postvasectomy

TRMP - Overview: Trimipramine, Serum

Monitoring trimipramine concentration during therapy Evaluating potential trimipramine toxicity May aid in evaluating patient compliance

VLTU - Overview: Volatile Screen, Random, Urine

Detecting the presence of acetone, methanol, isopropanol, or ethanol in urine with subsequent quantitation

VITE - Overview: Vitamin E, Serum

Monitoring of Vitamin E supplementation/treatment Potentially detecting Vitamin E overdoses

IGD - Overview: Immunoglobulin D (IgD), Serum

Providing information on the humoral immune status Identifying an IgD monoclonal gammopathy

FXIII - Overview: Factor XIII (13), Screen, Plasma

Screening for factor XIII deficiency

FELBA - Overview: Felbamate (Felbatol), Serum

Determining whether a poor therapeutic response is attributable to noncompliance or lack of drug effectiveness Monitoring changes in serum concentrations resulting from interactions with coadministered drugs such as barbiturates and...

F2_IS - Overview: Factor II Inhibitor Screen, Plasma

Detecting the presence of a specific factor inhibitor directed against coagulation factor II

IL1B - Overview: Interleukin-1 Beta, Plasma

Measuring the concentration of interleukin-1 beta in plasma Evaluating patients experiencing inflammatory conditions, autoinflammatory disorders, and infection

KIPM - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Manual

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases, using a manual method

KIBM - Overview: Ki-67(MIB-1), Breast, Semi-Quantitative Immunohistochemistry, Manual

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with breast carcinoma

APBCS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Cell-Binding Assay, Serum

The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Evaluating AP3B2 (adaptor protein 3 beta2)-IgG by cell-binding assay using serum specimens

AADAM - Overview: ADAMTS13 Profile Interpretation

Technical interpretation of a profile to assist with the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura including inhibitor studies

RCHLU - Overview: Chloride, Random, Urine

An indicator of fluid balance and acid-base homeostasis

COKEU - Overview: Cocaine and Metabolite Confirmation, Random, Urine

Detecting and confirming drug abuse involving cocaine This test is not intended for employment-related testing.

NOTRP - Overview: Nortriptyline, Serum

Monitoring nortriptyline concentration during therapy Evaluating potential nortriptyline toxicity May aid in evaluating patient compliance

NCDCC - Overview: Neurochondrin Antibody, Cell-Binding Assay, Spinal Fluid

Evaluating neurochondrin-IgG by cell-binding assay using spinal fluid from patients presenting with cerebellar and brainstem syndrome

NCDCS - Overview: Neurochondrin Antibody, Cell-Binding Assay, Serum

Evaluating neurochondrin-IgG by cell-binding assay using serum from patients presenting with cerebellar and brainstem syndrome

PBR - Overview: Phenobarbital, Serum

Monitoring for appropriate therapeutic concentration of phenobarbital Assessing compliance or toxicity

TPIC - Overview: Triosephosphate Isomerase Enzyme Activity, Blood

Evaluating individuals with chronic nonspherocytic hemolytic anemia Evaluating individuals with early onset neurologic impairment Genetic counseling for families with triosephosphate isomerase deficiency

DXPIN - Overview: Doxepin and Nordoxepin, Serum

Monitoring doxepin therapy Evaluating potential doxepin toxicity Evaluating patient compliance